SYSTEMATIC REVIEW
Accepted on 07 Mar 2025
Efficacy and Safety of PD-1/PD-L1 Inhibitors as First-Line Treatment for Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
doi 10.3389/fimmu.2025.1563300
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
Immune-Checkpoint Inhibitors and Immunometabolic Reprogramming in Cancer Immunotherapy
3,881
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Accepted on 24 Feb 2025
Successful Treatment of an Elderly Patient with Lung Squamous Cell Carcinoma by Tislelizumab and Chemotherapy: a Case Report with Novel Imaging Findings
doi 10.3389/fimmu.2025.1543114
SYSTEMATIC REVIEW
Accepted on 20 Feb 2025
Effectiveness and safety of ICIs for the treatment of advanced CC: A systematic review and meta-analysis
doi 10.3389/fimmu.2025.1542850
ORIGINAL RESEARCH
Published on 07 Feb 2025
NOX4 modulates breast cancer progression through cancer cell metabolic reprogramming and CD8+ T cell antitumor activity
doi 10.3389/fimmu.2025.1534936
- 902 views
OPINION
Published on 10 Dec 2024
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
doi 10.3389/fimmu.2024.1490129
- 731 views
- 1 citation
SYSTEMATIC REVIEW
Published on 18 Oct 2024
Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
doi 10.3389/fimmu.2024.1482746
- 1,118 views
REVIEW
Published on 04 Oct 2024
Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment
doi 10.3389/fimmu.2024.1441667
- 1,841 views
- 2 citations
SYSTEMATIC REVIEW
Published on 01 Oct 2024
Efficacy and safety of immune checkpoint inhibitors as neoadjuvant therapy in perioperative patients with non-small cell lung cancer: a network meta-analysis and systematic review based on randomized controlled trials
doi 10.3389/fimmu.2024.1432813
- 1,852 views
- 1 citation
OPINION
Published on 12 Jul 2024
Microbiota-metabolism-epigenetics-immunity axis in cancer
doi 10.3389/fimmu.2024.1449912
- 1,408 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: